Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-11
2008-03-11
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S311000, C514S314000, C514S313000, C546S153000, C546S159000, C546S171000
Reexamination Certificate
active
10466566
ABSTRACT:
The invention relates to the use of quinolines having general formula (I), wherein R1denotes H; alkyl C1-C15; alkenyl or alkynyl C2-C15; —CHO; heteroaryl; alkyl C1-C15or alkenyl or alkynyl C2-C7comprising at least one substituent selected from among O, halogen, —OH, —CHO, —COOH, aryloxycarbonyl, alkyloxycarbonyl C2-C8, alkenyloxycarbonyl C3-C9, nitrile, aryl, heteroaryl, arylsulphone, alkylsulphone C1-C7, thioalkyl or aminoalkyl C1-C7; alkenyl C2-C7bearing at least one substituent selected from among NH2, aleoxy C1-C7, phenoxy, cycloakyl C3-C6or heteroaryloxy, alkenyl or alkynyl C2-C15comprising at least one trialkylsilyl C1-C7; R2, in position 3, 6 or 8, denotes H; halogen; —OH; —CHO; —COOH; alkyl or aleoxy C1-C7; —NH2; alkenyl C2-C7; or alkynyl C2-C10; R1and R2do not both denote H. The invention is used for the preparation of a medicine to treat protozoan and retrovirus co-infections
REFERENCES:
patent: 3488728 (1970-01-01), Eichenberger et al.
patent: 5153202 (1992-10-01), Davis
patent: 5278173 (1994-01-01), Davis
patent: 6025390 (2000-02-01), Farina et al.
patent: 0 305 968 (1989-03-01), None
patent: 2 761 687 (1988-10-01), None
patent: WO 93/07125 (1993-04-01), None
patent: 00/44387 (2000-08-01), None
patent: 01/12155 (2001-02-01), None
patent: 01/16357 (2001-03-01), None
Manning, CA 46:30931, abstract of Australasian J Pharm, vol. 31, pp. 764-766, 1951.
Potts, CA 38:16662, abstract of Journal of the Franklin Institute, vol. 237, pp. 227-231, 1944.
Queener, Antimicrobial Agents and Chemotherapy, vol. 37, No. 10, pp. 2166-2172, 1993.
Tojo, J of Fish Diseases, vol. 17(2), pp. 135-143, 1994.
Ouali, J Med Chem, vol. 43, pp. 1949-1957, 2000.
International Search Report.
Fournet, A., et al.; The activity of 2-substituted quinoline alkaloids in BALB/c mice infected withLeishmania donovani, Chemical Abstracts, vol. 121, No. 7, Abstract No. 73107s (Aug. 15, 1994).
Mohamed A. Fakhfakh et al. Expeditious preparation of 2-substituted quinolines,Tetrahedron Letters, vol. 42, No. 23, pp. 3847-3850 (Jun. 4, 2001).
Austin et al., “SRN1 Reactions of aryl halides with carbanions initiated by sodium amalgam in liquid ammonia”,Tetrahedron, vol. 49, No. 21, pp. 4495-4502, 1993.
Fakhfakh Mohamed
Figadere Bruno
Fournet Alain
Franck Xavier
Hocquemiller Reynald
Alston & Bird LLP
Centre National de la Recherche Scientifique
Institut de Recherche pour le Developpement
Seaman D. Margaret
LandOfFree
Substituted quinolines for the treatment of protozoa and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted quinolines for the treatment of protozoa and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinolines for the treatment of protozoa and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3909018